Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
san diego blog main
san diego top stories
2
×
akcea therapeutics
anylam pharmaceuticals
bial
biotech
boston blog main
boston top stories
cardiomyopathy
drug development
drugs
fda
inotersen
national top stories
neurocrine
neurodegeneration
neuropathy
neuroscience
new york
new york blog main
new york top stories
onpattro
opicapone
parkinson's disease
patisiran
pfizer
san diego
tafamidis
tegsedi
transthyretin amyloidosis
What
disease
2
×
fda
patients
2
×
add
ago
akcea
alnylam
amyloidosis
approved
attr
available
battle
called
carbidopa
combination
control
daily
debilitating
drug
experience
genetic
gets
levodopa
medication
medicines
neurocrine
nod
oks
parkinson’s
pfizer
pill
rare
sets
symptoms
time
transthyretin
year
Language
unset
Current search:
disease
×
patients
×
" san diego top stories "
×
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea